Recent Finacing
Recent Raise
Neobe Therapeutics develops programmable engineered live biotherapeutics that remodel fibrotic tumor stroma and overcome immune-exclusion to enable immune cell infiltration, with preclinical candidates for colorectal, pancreatic and breast cancers.
